Document is current
Any future updates will be listed below
-
Authors
Fabro, Erica Alves Nogueira https://orcid.org/0000-0003-0959-7678
Costa, Rejane Medeiros https://orcid.org/0000-0002-8195-955X
Fernandes, Maíra Carneiro https://orcid.org/0009-0000-8799-7760
Ximenes, Matheus Albino https://orcid.org/0000-0003-2064-9336
Nogueira, Denismar Alves https://orcid.org/0000-0003-2285-8764
Soares, Nathalia Bordinhon https://orcid.org/0000-0003-3667-7331
Thuler, Luiz Claudio Santos https://orcid.org/0000-0003-2550-6537
Bergmann, Anke https://orcid.org/0000-0002-1972-8777
- License Information
-
More Information
Article History
Received: 8 May 2024
Accepted: 13 September 2024
First Online: 25 September 2024
Declarations
:
: This study was approved by the National Cancer Institute Research Ethics Committee (CEP-INCA), Rio de Janeiro, Brazil, under no. 2,774,824, in compliance with the rules provided for research on human subjects contained in the Resolution of the National Health Council Nº 466/2012 and Operational Standard of the National Health Council N<sup>o</sup> 001/2013, in accordance with the Declaration of Helsinki.This clinical trial is registered at Clinical Trials.gov under identifier no. NCT04471142.
: The authors declare no competing interests.
